This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Novavax Inc (NVAX)

: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 36.25M 30.66M 20.91M 22.08M
Cost of Sales 0.00 10.15M 5.12M 13.04M
Gross Operating Profit 36.25M 20.51M 15.79M 9.03M
Selling, General, and Administrative Expenses 30.84M 19.93M 14.82M 10.99M
Research & Development 162.64M 79.44M 50.31M 26.06M
Operating Income before D & A (EBITDA) -157.24M -78.85M -49.34M -28.02M
Depreciation & Amortization 7.20M 4.84M 3.10M 1.65M
Interest Income 660.00K 286.00K 187.00K 165.00K
Other Income - Net -120.00K 615.00K 449.00K 1.02M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -163.90M -82.79M -51.80M -28.48M
Interest Expense 241.00K 157.00K 160.00K 32.00K
Pre-Tax Income -164.14M -82.95M -51.96M -28.51M
Income Taxes 0.00 0.00 25.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -156.94M -82.95M -51.98M -28.51M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -156.94M -82.95M -51.98M -28.51M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -156.94M -82.95M -51.98M -28.51M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-156.94M -82.95M -51.98M -28.51M
Preferred Dividends
Net Income Available To Common -156.94M -82.95M -51.98M -28.51M
Basic EPS from Continuing Ops. -0.60 -0.37 -0.31 -0.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.60 -0.37 -0.31 -0.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.60 -0.37 -0.31 -0.22
Basic Normalized Net Income/Share -0.60 -0.37 -0.31 -0.22
EPS fr Continuing Ops. -0.60 -0.37 -0.31 -0.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.60 -0.37 -0.31 -0.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.60 -0.37 -0.31 -0.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.60 -0.37 -0.31 -0.22
Dividends Paid per Share 0.00 0.00 0.00 0.00
NVAX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for NVAX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NVAX ANALYST REPORT

NVAX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs